APA (7th ed.) Citation

CD, F., ED, D., T, H., V, M., A, W., M, S., . . . M, T. (2022). Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2-/- mouse model of sclerosing cholangitis via immunomodulatory effects. Hepatology communications, 6(9), 2368. https://doi.org/10.1002/hep4.1998

Chicago Style (17th ed.) Citation

CD, Fuchs, et al. "Tetrahydroxylated Bile Acids Improve Cholestatic Liver and Bile Duct Injury in the Mdr2-/- Mouse Model of Sclerosing Cholangitis via Immunomodulatory Effects." Hepatology Communications 6, no. 9 (2022): 2368. https://doi.org/10.1002/hep4.1998.

MLA (9th ed.) Citation

CD, Fuchs, et al. "Tetrahydroxylated Bile Acids Improve Cholestatic Liver and Bile Duct Injury in the Mdr2-/- Mouse Model of Sclerosing Cholangitis via Immunomodulatory Effects." Hepatology Communications, vol. 6, no. 9, 2022, p. 2368, https://doi.org/10.1002/hep4.1998.